Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 32 (4), 596-602
- https://doi.org/10.1016/s0168-8278(00)80221-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patientsHepatology, 1997
- Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter studyHepatology, 1995
- Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patientsAntimicrobial Agents and Chemotherapy, 1993
- A prospective study of bacterial infections in patients with cirrhosisJournal of Hepatology, 1993
- Aztreonam vs. cefotaxime in the treatment of gram-negative spontaneous peritonitis in cirrhotic patientsHepatology, 1991
- Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitisGastroenterology, 1991
- Amoxicillin–Clavulanic Acid Therapy of Spontaneous Bacterial Peritonitis: A Prospective Study of Twenty–Seven Cases in Cirrhotic PatientsHepatology, 1990
- Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis†Hepatology, 1989
- Problems of bacterial infection in patients with liver disease.Gut, 1987
- Cefotaxime Is More Effective Than Is Ampicillin–Tobramycin in Cirrhotics With Severe InfectionsHepatology, 1985